SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sigyn Therapeutics, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $48.16K
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Sigyn Therapeutics from other investors
No posts about SIGY yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.